WHIEDA: who is behind the products
We went digging in state registers instead of presentations
In brief
- Chinese state license TJ20160005 — fewer than a hundred licenses have been issued for the whole country.
- The WHIEDA trademark in the US Principal Register, reg. no. 7751216.
- Garmoniya LLC: revenue of 2.3 billion ₽ for 2025, the owners match the alliance's leadership.
- Asteroid 8311 Zhangdaning — named after the scientific advisor by decision of the International Astronomical Union.
- What didn't check out: “1000 patents”, “100 institutes”, “the world's largest factory” — and why that's a good sign.
Chinese companies are always described the same way: factories, science, international standards, government support. You listen and realize — there's nothing to hold on to. Not a single figure you could go and check.
We came at it from a different angle. We opened the registers of four countries — and it turned out to be more interesting there than in the presentations.
A state license, two Nobel Prizes nearby and an asteroid.
Behind the products is a Chinese manufacturer with a license that can't be bought, a trademark in the US Principal Register and a Russian legal entity with a turnover of 2.3 billion rubles. Some of the big numbers from the presentations didn't pass the check — we'll tell you about that too.
You've already googled it. And drowned
The search results are either distributor sites full of enthusiasm, or posts from regional branches with figures like “1000 patents” and “100 research institutes”. The trouble with these figures isn't their size. The trouble is that there's no number, no register, no link behind them — the source is a promotional post, not a document.
What can be checked is something else entirely: licenses, trademarks, legal entities, astronomical catalogs, certificates with numbers. That's where we went.
Six things you can check in five minutes
The company controls none of these sources. Details unfold under each item.
Learn more
Tianjin-based 和治友德 — a.k.a. FOHERB, the alliance's main shareholder — has held license TJ20160005 since 2016, the seventy-fourth issued in the country. After the wave of pyramid schemes in the nineties, China first banned this model entirely and then brought it back under a licensing regime: the requirements for capital, payout structure and reporting weed out almost everyone who applies.
Learn more
The mark was registered on April 8, 2025, the application was filed on June 12, 2024, and it was entered in the Principal Register — the main US register, which doesn't accept weak or descriptive marks. This also legally fixes what the abbreviation stands for.
Learn more
Operating since November 2020. Net profit 838 million, taxes paid 346 million, equity ratio 0.66. No commercial court cases, no bankruptcy, no signs of a shell company.
Learn more
The name is proposed by the object's discoverer and approved by the Working Group of the International Astronomical Union — fifteen professional astronomers. The rules explicitly prohibit names that could be confused with a trademark or product.
Learn more
This is the mechanism by which a cell dismantles and disposes of worn-out proteins — an intracellular waste-disposal service. Professor Ciechanover took part in the alliance's events; details below.
Learn more
The very same graphene that sits in the frame of the computer glasses as part of the PA6/G composite. The material wasn't dreamed up by marketers: a Nobel Prize was awarded for it, and it went to alumni of the Russian scientific school.
A license that can't be faked
This is the most underrated fact in the whole story, and it's exactly where getting to know the company should start.
In China, direct selling is licensed by the state. After the wave of pyramid schemes in the nineties, the authorities first banned the model entirely and then brought it back — but under a licensing regime. The requirements for capital, payout structure, product quality and reporting are such that fewer than a hundred licenses have been issued for all of China.
Tianjin-based 和治友德 — the very same FOHERB that owns the majority stake in the alliance — has held this license since 2016, the seventy-fourth issued. The register of licensed companies and this company's page are on the website of the PRC Ministry of Commerce.
The difference between a license and a pretty number is simple: behind a licensed company stands the regulator that issued it. It's not decoration for a presentation, it's someone else's signature under your reputation.
An asteroid was named after their scientific advisor
When we read this, the reaction was predictable: sure, and they were probably given a star too — one of those sold as gift certificates for three thousand rubles.
Turned out — it's true. NASA's Small-Body Database contains the object 8311 Zhangdaning (1996 TV1), a main-belt asteroid. It can be found by its number in a minute.
And here's the important difference from gift certificates. An asteroid can't be bought and can't be ordered — it isn't a service. The name is proposed by the object's discoverer and approved by the Working Group of the International Astronomical Union: fifteen professional astronomers from around the world. The rules explicitly prohibit names that could be confused with a trademark or product — so by definition it can't be a marketing stunt.
Whether that makes the insoles work is a separate question. But it says a lot about the man: Professor Zhang Daning is an academician of the Eurasian Academy of Sciences and one of the founders of nephrology in traditional Chinese medicine. Names like that don't end up in the minor planet catalog by accident.
Here, what usually doesn't match up matched up
Import and distribution in Russia are handled by Garmoniya LLC, TIN 9701164645, Moscow, operating since November 2020.
The company has two owners: Qu Junsheng — 66.7% and Liu Ting — 33.3%, who has also been the general director since the very founding.
Now compare that with what the alliance says about itself. Qu Junsheng is the executive chairman of WHIEDA and president of Fohow (Tianjin) Pharmaceutical. Liu Ting is the chairman of the Eurasian Association and president of Health Priority, the man with whom it all began in 2015.
It matches. And this isn't a slide from a presentation: information is submitted to the register under legal liability, anyone can see it, and it can't be retrofitted to a pretty legend after the fact. And the director hasn't changed since 2020 — in an industry where legal entities are sometimes re-registered every couple of years, that's a telling sign in itself.
Revenue grew almost ninefold in a year: from 258 million to 2.3 billion. An equity ratio of 0.66 means the business runs on its own money, not borrowed. No commercial court cases, no bankruptcy, no signs of a shell company.
Strictly speaking, you don't build a trend on a single year — a one-off deal can produce growth like that too. But seven people on staff and ninefold growth don't square well with the story of a mighty sales department. It looks more like something else: the product sells itself. Someone tried it, saw the result, told three others. That is exactly how things that work grow, and exactly how something that was pushed on someone once does not.
What is known about Aaron Ciechanover
The company's materials mention Professor Aaron Ciechanover — winner of the 2004 Nobel Prize in Chemistry, awarded jointly with Avram Hershko and Irwin Rose for the discovery of ubiquitin-mediated protein degradation. Put simply, for how a cell breaks down and disposes of worn-out proteins. The prize is confirmed on the Nobel Committee's website.
Here is what is known for certain: the professor took part in the alliance's events, and this is documented in photographs with official banners.
- A strategy seminar on biotechnology products. The banner reads “Laureate of the Nobel Prize in Chemistry, Aaron Ciechanover” and “WHIEDA Biotechnology Product Strategy Seminar”. Round-table format, about ten participants.
- The first biotechnology conference of the WHIEDA International Association: “中医养生智慧 · 现代生物科技”, which the Russian translation on the same banner renders as “Centuries-old wisdom of health preservation in traditional Chinese medicine. Modern biotechnology”. An international line-up of participants on stage.
There are no publicly available contracts about his role — and, frankly, there are unlikely to be. Agreements with scientists of this level are covered by non-disclosure terms; publishing the contract would be a direct breach of them. The absence of a document on the internet proves nothing here, one way or the other.
So we say exactly what the pictures show: a scientist of this caliber comes to the company's events, sits at the same table as its management and takes the stage under its logo. People with a Nobel Prize are usually quite particular about whose banners end up behind their backs.
How many countries, really
The company's materials mention “20+”, “30+” and “39+ countries”. We won't name an exact figure, and here's why: with ninefold growth in a year, any number we give will be out of date before you finish reading this line.
The geography, however, can be checked right now, without any figures. The company runs local official websites in various countries — for example, the British and Uzbek. Representative offices are open in Moscow, Istanbul, Astana, Almaty, Bishkek, Tashkent and Ulaanbaatar. Launching a site in another language with a local legal entity behind it is more expensive and slower than adding a figure to a presentation.
Since we've dug into the registers, let's be honest about the other side too.
- “1000+ patents” and “100+ research institutes”. The source of these figures is a promotional post by a regional branch; they are not backed by documents, and we don't use them: a skeptic will rightly ask for the numbers. The insoles, on the other hand, have a specific design patent that opens via a link, and a Russian certificate with a number in the state register. One document with a number weighs more than a thousand that can't be found.
- “The largest factory in the world, 40,000 sq. m”. Four hectares is a decent production facility, but “the largest in the world” doesn't hold up to scrutiny: big pharma has facilities an order of magnitude larger. We drop the superlative and keep the area: it is a real high-altitude spirulina production site that partners visit themselves and film videos at.
- “Capitalization of 500 million dollars”. A figure from a slide in their own presentation; a private alliance has no independent audit. But here is what can be calculated: Russia alone brought in 2.3 billion rubles of revenue in a year — about 25 million dollars. From one country out of several dozen. Against that backdrop, 500 million for all the combined assets looks more like an underestimate.
The bottom line
A Chinese state license that cannot be bought. A trademark in the principal US register. A Russian legal entity with a turnover of 2.3 billion and owners who match the stated management. 55 documents that open via a link. An asteroid named by decision of an international astronomical committee. A Nobel laureate on stage under their logo.
And separately — a thousand patents and a hundred institutes we could not find, and the largest factory in the world that in fact turned out to be simply large.
The difference between these two lists is the answer to the question of who is behind the products. The company turned out to be noticeably more real than the enthusiastic posts make it look, and noticeably more modest than those same posts suggest. In our experience, that is the best possible outcome of a check: it's where absolutely everything adds up that you should start to worry.